126 related articles for article (PubMed ID: 27104637)
1. Subacute Cardiotoxicity of Yessotoxin: In Vitro and in Vivo Studies.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Cantalapiedra AG; Santamarina G; Cifuentes JM; Vieira AC; Botana LM
Chem Res Toxicol; 2016 Jun; 29(6):981-90. PubMed ID: 27104637
[TBL] [Abstract][Full Text] [Related]
2. Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX.
Ferreiro SF; Carrera C; Vilariño N; Louzao MC; Santamarina G; Cantalapiedra AG; Botana LM
Toxins (Basel); 2015 Mar; 7(4):1030-47. PubMed ID: 25826053
[TBL] [Abstract][Full Text] [Related]
3. Subacute immunotoxicity of the marine phycotoxin yessotoxin in rats.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Cifuentes JM; Vieira AC; Botana LM
Toxicon; 2017 Apr; 129():74-80. PubMed ID: 28209479
[TBL] [Abstract][Full Text] [Related]
4. In vivo cardiomyocyte response to YTX- and AZA-1-induced damage: autophagy versus apoptosis.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Cifuentes JM; Crespo A; Botana LM
Arch Toxicol; 2017 Apr; 91(4):1859-1870. PubMed ID: 27709272
[TBL] [Abstract][Full Text] [Related]
5. Subacute Cardiovascular Toxicity of the Marine Phycotoxin Azaspiracid-1 in Rats.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Cantalapiedra AG; Santamarina G; Cifuentes JM; Vieira AC; Botana LM
Toxicol Sci; 2016 May; 151(1):104-14. PubMed ID: 26865666
[TBL] [Abstract][Full Text] [Related]
6. Repeated oral co-exposure to yessotoxin and okadaic acid: a short term toxicity study in mice.
Sosa S; Ardizzone M; Beltramo D; Vita F; Dell'Ovo V; Barreras A; Yasumoto T; Tubaro A
Toxicon; 2013 Dec; 76():94-102. PubMed ID: 24060376
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural damage to heart tissue from repeated oral exposure to yessotoxin resolves in 3 months.
Tubaro A; Giangaspero A; Ardizzone M; Soranzo MR; Vita F; Yasumoto T; Maucher JM; Ramsdell JS; Sosa S
Toxicon; 2008 Jun; 51(7):1225-35. PubMed ID: 18402996
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes.
Dell'Ovo V; Bandi E; Coslovich T; Florio C; Sciancalepore M; Decorti G; Sosa S; Lorenzon P; Yasumoto T; Tubaro A
Toxicol Sci; 2008 Dec; 106(2):392-9. PubMed ID: 18799716
[TBL] [Abstract][Full Text] [Related]
9. Yessotoxins: a toxicological overview.
Tubaro A; Dell'ovo V; Sosa S; Florio C
Toxicon; 2010 Aug; 56(2):163-72. PubMed ID: 19660487
[TBL] [Abstract][Full Text] [Related]
10. In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Rodríguez LP; Cifuentes JM; Vieira AC; Nicolaou KC; Frederick MO; Botana LM
Arch Toxicol; 2014 Feb; 88(2):425-34. PubMed ID: 23934164
[TBL] [Abstract][Full Text] [Related]
11. Potent neurotoxic action of the shellfish biotoxin yessotoxin on cultured cerebellar neurons.
Pérez-Gómez A; Ferrero-Gutierrez A; Novelli A; Franco JM; Paz B; Fernández-Sánchez MT
Toxicol Sci; 2006 Mar; 90(1):168-77. PubMed ID: 16322070
[TBL] [Abstract][Full Text] [Related]
12. In vitro chronic effects on hERG channel caused by the marine biotoxin azaspiracid-2.
Ferreiro SF; Vilariño N; Louzao MC; Nicolaou KC; Frederick MO; Botana LM
Toxicon; 2014 Dec; 91():69-75. PubMed ID: 25286396
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of yessotoxin and okadaic acid in mouse T lymphocyte cell line EL-4.
Martín-López A; Gallardo-Rodríguez JJ; Sánchez-Mirón A; García-Camacho F; Molina-Grima E
Toxicon; 2012 Nov; 60(6):1049-56. PubMed ID: 22858382
[TBL] [Abstract][Full Text] [Related]
14. Yessotoxin, a Promising Therapeutic Tool.
Alfonso A; Vieytes MR; Botana LM
Mar Drugs; 2016 Jan; 14(2):. PubMed ID: 26828502
[TBL] [Abstract][Full Text] [Related]
15. Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice.
Tubaro A; Sosa S; Carbonatto M; Altinier G; Vita F; Melato M; Satake M; Yasumoto T
Toxicon; 2003 Jun; 41(7):783-92. PubMed ID: 12782078
[TBL] [Abstract][Full Text] [Related]
16. Yessotoxin, a shellfish biotoxin, is a potent inducer of the permeability transition in isolated mitochondria and intact cells.
Bianchi C; Fato R; Angelin A; Trombetti F; Ventrella V; Borgatti AR; Fattorusso E; Ciminiello P; Bernardi P; Lenaz G; Parenti Castelli G
Biochim Biophys Acta; 2004 Jun; 1656(2-3):139-47. PubMed ID: 15178475
[TBL] [Abstract][Full Text] [Related]
17. First report on azaspiracid and yessotoxin groups detection in French shellfish.
Amzil Z; Sibat M; Royer F; Savar V
Toxicon; 2008 Jul; 52(1):39-48. PubMed ID: 18573273
[TBL] [Abstract][Full Text] [Related]
18. Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice.
Aasen JA; Espenes A; Miles CO; Samdal IA; Hess P; Aune T
Toxicon; 2011 May; 57(6):909-17. PubMed ID: 21426911
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol.
Yoon KS; Lee JM; Kim YH; Suh SK; Cha HJ
Toxicol Lett; 2020 Feb; 319():40-48. PubMed ID: 31706004
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of yessotoxin stabilizes E-cadherin in mouse colon.
Callegari F; Sosa S; Ferrari S; Soranzo MR; Pierotti S; Yasumoto T; Tubaro A; Rossini GP
Toxicology; 2006 Oct; 227(1-2):145-55. PubMed ID: 16950554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
